Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tugba Gulsun"'
Autor:
Tugba Gulsun, Selma Sahin
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 261-4 (2020)
The oral route is the most preferred route for drug administration because of patient compliance. Following oral administration, a drug has to cross several biological barriers before reaching the systemic circulation by transcellular or paracellular
Externí odkaz:
https://doaj.org/article/47f52cb8bba641dfab9cc1dc63420c81
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 265-9 (2020)
Oral disintegrating tablets (ODT) are orally administered solid dosage forms commonly used in pediatric and geriatric patients with difficulty in swallowing. The lack of need for water during the use of ODTs is another advantage that increases patien
Externí odkaz:
https://doaj.org/article/174b321dcbc149df85198d03bd0c4a6d
Publikováno v:
Journal of Research in Pharmacy. 26:383-396
Publikováno v:
Canadian journal of physiology and pharmacology.
Permeability enhancers can affect absorption of paracellularly transported drugs. This study aims to evaluate effects of permeability enhancers (chitosan, methyl- β -cyclodextrin, sodium caprate, sodium lauryl sulfate, etc.) on the permeability of p
Publikováno v:
Pharmacology. 106:390-399
Introduction: Alzheimer’s disease (AD) is a severe neurodegenerative disorder of the brain characterized by degeneration of cholinergic neurons which is directly linked to cognitive decline. Nerve growth factor (NGF) is the most potent protective f
Publikováno v:
Drug Delivery with Targeted Nanoparticles ISBN: 9781003164739
Drug Delivery with Targeted Nanoparticles
Drug Delivery with Targeted Nanoparticles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfa9bdc5c007533348f0d0eeca74ab47
https://doi.org/10.1201/9781003164739-1
https://doi.org/10.1201/9781003164739-1
Publikováno v:
Drug Delivery with Targeted Nanoparticles ISBN: 9781003164739
Drug Delivery with Targeted Nanoparticles
Drug Delivery with Targeted Nanoparticles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::778eb1e1123d3ae00c34303249d7c1f8
https://doi.org/10.1201/9781003164739-14
https://doi.org/10.1201/9781003164739-14
Furosemide is a widely used diuretic drug for the treatment of edema associated with heart, liver cirrhosis, renal diseases and hypertension. It is a Class IV drug with low aqueous solubility and low permeability according to Biopharmaceutics Classif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7d20d681286d162bde0ccb03f4b868a
https://hdl.handle.net/11491/7424
https://hdl.handle.net/11491/7424
Publikováno v:
AAPS PharmSciTech. 21
Rivaroxaban (RXB) is a class II drug, according to the Biopharmaceutics Classification System. Since its bioavailability is low at high doses, dose proportionality is not achieved for pharmacokinetic parameters. However, when taken with food, its bio
Publikováno v:
Pharmaceutical development and technology. 25(8)
Diabetes is characterized by chronic hyperglycemia. Although metformin hydrochloride (MHCl)- and glyburide (GLB)-containing conventional tablets are available in the market and used to treat diabetes, orally disintegrating tablets (ODTs) containing t